STUB1 and melanoma: Having observed an enhanced sensitivity of STUB1-deficient melanoma cells to cytotoxic T cell-derived IFNγ in vitro (Fig. 4), we next investigated the effects of enhanced IFNγ signaling and its relationship to anti-PD-1 treatment in vivo.